Sanara MedTech Statistics
Total Valuation
Sanara MedTech has a market cap or net worth of $245.70 million. The enterprise value is $274.20 million.
Important Dates
The next confirmed earnings date is Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sanara MedTech has 8.90 million shares outstanding. The number of shares has increased by 1.87% in one year.
| Current Share Class | 8.90M |
| Shares Outstanding | 8.90M |
| Shares Change (YoY) | +1.87% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 31.18% |
| Owned by Institutions (%) | 18.19% |
| Float | 3.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.43 |
| Forward PS | 2.11 |
| PB Ratio | 6.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2,983.05 |
| P/OCF Ratio | 67.36 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 275.19, with an EV/FCF ratio of 3,328.97.
| EV / Earnings | n/a |
| EV / Sales | 2.82 |
| EV / EBITDA | 275.19 |
| EV / EBIT | n/a |
| EV / FCF | 3,328.97 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 1.28.
| Current Ratio | 2.26 |
| Quick Ratio | 1.95 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 29.63 |
| Debt / FCF | 551.81 |
| Interest Coverage | -0.65 |
Financial Efficiency
Return on equity (ROE) is -26.38% and return on invested capital (ROIC) is -3.11%.
| Return on Equity (ROE) | -26.38% |
| Return on Assets (ROA) | -2.50% |
| Return on Invested Capital (ROIC) | -3.11% |
| Return on Capital Employed (ROCE) | -4.11% |
| Revenue Per Employee | $689,659 |
| Profits Per Employee | -$70,481 |
| Employee Count | 141 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 2.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.49% in the last 52 weeks. The beta is 1.15, so Sanara MedTech's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -17.49% |
| 50-Day Moving Average | 31.76 |
| 200-Day Moving Average | 31.07 |
| Relative Strength Index (RSI) | 37.08 |
| Average Volume (20 Days) | 24,317 |
Short Selling Information
The latest short interest is 206,746, so 2.32% of the outstanding shares have been sold short.
| Short Interest | 206,746 |
| Short Previous Month | 195,319 |
| Short % of Shares Out | 2.32% |
| Short % of Float | 5.78% |
| Short Ratio (days to cover) | 8.96 |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $97.24 million and -$9.94 million in losses. Loss per share was -$1.16.
| Revenue | 97.24M |
| Gross Profit | 89.23M |
| Operating Income | -3.45M |
| Pretax Income | -10.13M |
| Net Income | -9.94M |
| EBITDA | 996,405 |
| EBIT | -3.45M |
| Loss Per Share | -$1.16 |
Full Income StatementBalance Sheet
The company has $16.96 million in cash and $45.45 million in debt, giving a net cash position of -$28.49 million or -$3.20 per share.
| Cash & Cash Equivalents | 16.96M |
| Total Debt | 45.45M |
| Net Cash | -28.49M |
| Net Cash Per Share | -$3.20 |
| Equity (Book Value) | 35.39M |
| Book Value Per Share | 3.98 |
| Working Capital | 18.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.65 million and capital expenditures -$3.57 million, giving a free cash flow of $82,367.
| Operating Cash Flow | 3.65M |
| Capital Expenditures | -3.57M |
| Free Cash Flow | 82,367 |
| FCF Per Share | $0.01 |
Full Cash Flow StatementMargins
Gross margin is 91.76%, with operating and profit margins of -3.55% and -10.22%.
| Gross Margin | 91.76% |
| Operating Margin | -3.55% |
| Pretax Margin | -10.42% |
| Profit Margin | -10.22% |
| EBITDA Margin | 1.02% |
| EBIT Margin | -3.55% |
| FCF Margin | 0.08% |
Dividends & Yields
Sanara MedTech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.87% |
| Shareholder Yield | -1.87% |
| Earnings Yield | -4.04% |
| FCF Yield | 0.03% |
Analyst Forecast
The average price target for Sanara MedTech is $50.00, which is 81.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $50.00 |
| Price Target Difference | 81.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 10, 2019. It was a reverse split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Sanara MedTech has an Altman Z-Score of 3.16 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.16 |
| Piotroski F-Score | 5 |
